U.S. Treasurys popping to end the week as the 2 Year hits a near two-decade high and the 10 Year reaches highs not seen since January 2025. The traders break down the reason behind the surge and if this could affect the next Fed rate decision. Then, Novo Nordisk tumbling after a heart medicine trial failure. Mizuho securities healthcare sector specialist Jared Holz lays out how the company can coarse correct, and what this means for the broader pharmaceutical space. Plus, Amazon surging 15% on the back of its earnings while Exxon loses steam, and counting down to SpaceX’s earnings report as the aerospace giant trades well below its IPO price.<br><br>Fast Money Disclaimer<br><br>Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Treasurys Turn Higher… And Novo Sinks After Trial Failure 7/31/26

CNBC's "Fast Money"

Trading at Schwab is now powered by Ameritrade. Unlocking the power of Thinkorswim, the award-winning trading platforms loaded with features that let you dive deeper into the market. Visualize your trades in a new light on Thinkorswim Desktop with robust charting and analysis tools. All while you uncover new opportunities with up-to-the-minute market news and insights. Thinkorswim is available on desktop, web, and mobile to meet you where you are. It's built by the trading obsessed to help you trade brilliantly. Learn more at schwab.com slash trading.

When you partner with CDW, you get more from your devices with solutions that take modern work to the next level. CDW experts are delivering powerful productivity with Lenovo AI PCs. Helping users block out distractions, access virtual support anytime, anywhere, and share content seamlessly between devices. Make amazing happen. Learn more at cdw.com slash Lenovo.

Live from the Nasdaq Market site in the heart of New York City's Times Square, this is Fast Money. Here's what's on tap tonight. Yields spiking. The tenure hitting 18-month highs while the 30-year is at levels not seen since 2007. What's driving these moves and what does it mean for the broader market? And pipeline problems for Novo Nordisk, why the company's latest drug trial results and shares sliding today.

A top expert weighs in. Plus, Amazon and Apple move in vastly different directions. Software stocks get their group back. And the countdown for SpaceX shares hitting another new low ahead of earnings and a lockup expiration. What the options markets are saying about the stock right now. I'm Melissa Lee. Come to you live in studio. Be at the Nasdaq. On the desk tonight, Courtney Garcia, Steve Grasso, Bono & Eisen, and Tim Seymour will join us shortly.

Treasurys Turn Higher… And Novo Sinks After Trial Failure 7/31/26

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Treasurys Turn Higher… And Novo Sinks After Trial Failure 7/31/26

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.